(Press-News.org) A new risk-stratification tool which can accurately predict the likelihood of deterioration in adults hospitalised with COVID-19 has been developed by researchers from the UK Coronavirus Clinical Characterisation Consortium (known as ISARIC4C).
Researchers say the online tool, made freely available to NHS doctors from today (Friday 8 January 2021), could support clinicians' decision making - helping to improve patient outcomes and ultimately save lives.
The tool assesses 11 measurements* routinely collected from patients, including age, gender, and physical measurements (such as oxygen levels) along with some standard laboratory tests and calculates a percentage risk of deterioration, known as the '4C Deterioration Score'.
This innovation, published in The Lancet Respiratory Medicine, builds on the Consortium's previous work developing the '4C Mortality Score' to predict the percentage risk of death from COVID-19 after admission to hospital. The '4C Mortality Score' is already recommended for use by NHS England** to guide anti-viral treatments (Remdesivir).
Doctors will now see both the '4C Deterioration Score' and the '4C Mortality Score' at the same time, using the same tool.
Co-senior and corresponding author, Professor Mahdad Noursadeghi (UCL Infection & Immunity), said: "Accurate risk-stratification at the point of admission to hospital will give doctors greater confidence about clinical decisions and planning ahead for the needs of individual patients.
"The addition of the new 4C Deterioration Score alongside the 4C Mortality Score will provide clinicians with an evidence-based measure to identify those who will need increased hospital support during their admission, even if they have a low risk of death."
The tool was developed using data from 74,944 individuals with COVID-19*** admitted to 260 hospitals across England, Scotland and Wales, between February 6 and August 26, 2020.
Using a multivariable logistic regression model (where several measures are used to predict an outcome), researchers tested the 11 measures (age/gender/physical measures/lab tests) against the large patient cohort, to establish how, and to what to degree each of the measures affected the likelihood of deterioration.
Furthermore, researchers assessed how well the tool performed in nine NHS regions and found that it performed similarly well in each, suggesting that it is likely to be useful across the NHS. Importantly, the new risk score showed superior performance across the NHS, in comparison to previous risk scores.
First author Dr Rishi Gupta (UCL Institute of Global Health) said: "The scale and wide geographical coverage of the ISARIC4C study across the country was critical to the development of this prediction tool. Our analysis provides very encouraging evidence that the 4C Deterioration tool is likely to be useful for clinicians across England, Scotland and Wales to support clinical decision-making."
The tool can potentially be incorporated into NHS Trusts' Electronic Health Record System - used to manage all patient care - so that risk scores are automatically generated for patients.
Researchers suggest that the tool could also be used in other countries for risk-stratification, but should first be evaluated to test its accuracy in these settings.
INFORMATION:
ISARIC4C is a UK-wide consortium of NHS doctors and scientists from universities including UCL, Imperial College London, the University of Liverpool, the University of Edinburgh, and the University of Oxford.
It is principally funded by grants from the National Institute for Health Research (NIHR) and UK Medical Research Council.
*The 11 measures (demographic, clinical, and laboratory predictors) are age; gender; acquisition of infection in hospital or community; existence of infiltrates (white spots) on lung X-Ray; impairment of consciousness level (defined by the Glasgow Coma Scale); respiratory rate (breaths per minute); oxygen saturation (measured with a finger probe); blood C-reactive protein levels; level of urea (in blood); number of lymphocytes in blood; and whether or not the patient is receiving oxygen (from a breathing aid).
** NHS England guidance: Interim Clinical Commissioning Policy: Remdesivir for patients hospitalised with COVID-19 https://www.england.nhs.uk/coronavirus/publication/interim-clinical-commissioning-policy-remdesivir-for-patients-hospitalised-with-covid-19-adults-and-children-12-years-and-older/
***For this modelling study adults (18 or over) who had highly suspected or confirmed COVID-19 were included.
Notes to Editors
For a copy of the paper or to speak with the researchers, please contact Henry Killworth, UCL Media Relations. T: +44 (0) 7881 833274 E: h.killworth@ucl.ac.uk.
Research paper: Rishi K Gupta, Peter Openshaw, J Kenneth Baillie, Malcolm Semple, Mahdad Noursadeghi, on behalf of the ISARIC4C Investigators, 'Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study' will be published in the Lancet Respiratory Medicine at 23:30 (UK Time) on Friday 8th January 2021/ 18:30 (Eastern Time).
The DOI will be: 10.1016/S2213-2600(20)30559-2.
ISARIC4C website: https://isaric4c.net/
About UCL - London's Global University
UCL is a diverse community with the freedom to challenge and think differently.
Our community of more than 41,500 students from 150 countries and over 12,500 staff pursues academic excellence, breaks boundaries and makes a positive impact on real world problems.
We are consistently ranked among the top 10 universities in the world and are one of only a handful of institutions rated as having the strongest academic reputation and the broadest research impact.
We have a progressive and integrated approach to our teaching and research - championing innovation, creativity and cross-disciplinary working. We teach our students how to think, not what to think, and see them as partners, collaborators and contributors.
For almost 200 years, we are proud to have opened higher education to students from a wide range of backgrounds and to change the way we create and share knowledge.
We were the first in England to welcome women to university education and that courageous attitude and disruptive spirit is still alive today.
We are UCL.
http://www.ucl.ac.uk| Follow @uclnews on Twitter | Watch our YouTube channel | Listen to UCL podcasts on SoundCloud | Find out what's on at UCL Minds | #MadeAtUCL
Find out how UCL is helping lead the global fight against COVID-19 http://www.ucl.ac.uk/covid-19-research
Study of 1,733 patients first diagnosed in Wuhan (China) between January and May followed to June and September.
76% of COVID-19 patients have at least one symptom six months after symptom onset.
Fatigue or muscle weakness is the most common symptom, with sleep difficulties and anxiety or depression also frequently reported.
Lower antibodies against COVID-19 in patients six months after becoming ill compared with during acute infection raises concerns about the possibility of re-infection.
More than three quarters of COVID-19 patients have at least one ongoing symptom six months after initially becoming unwell, according to research published in The Lancet.
The cohort study, looking at long-term effects of COVID-19 infection on people hospitalised ...
COVID-19 patients admitted to intensive care in the early months of the pandemic were subject to a significantly higher burden of delirium and coma than is typically found in patients with acute respiratory failure. Choice of sedative medications and curbs on family visitation played a role in increasing acute brain dysfunction for these patients.
That's according to an international study published Jan. 8 in The Lancet Respiratory Medicine, led by researchers at Vanderbilt University Medical Center in coordination with researchers in Spain.
The study, which is far the largest of its kind to date, tracks the incidence of delirium and coma in 2,088 COVID-19 patients admitted before April 28, 2020, to 69 adult intensive care units across 14 countries.
ICU delirium is ...
Hundreds of cancer patients have benefitted from using computer algorithms to manage their symptoms and improve their wellbeing in a unique UK trial.
The early stage colorectal, breast or gynecological cancer patients took part in the trial of the eRAPID system, developed by the University of Leeds, which allowed them to report online symptoms from home and receive instant advice on whether to self-manage or seek medical attention.
Patients reported better symptom control and physical wellbeing in the early weeks of treatment, with the system preventing symptom deterioration in about 9% of patients after 12 weeks. Patients reported more confidence in managing ...
A year ago, trying to find patients who would agree to see their University of Michigan mental health provider through a video screen felt like pulling teeth.
Only 26 video visits with a few early-adopters had happened in nearly six months, compared with more than 30,000 in-person visits.
But Jennifer Severe, M.D., one of the three psychiatrists who helped launch a test of telehealth initiatives in the U-M's outpatient psychiatry clinic, wasn't about to give up.
She prepared to give a talk at the beginning of April of 2020, hoping to convince more of her colleagues to give telepsychiatry a try, now that a major insurance ...
Eating a healthy diet, such as the Mediterranean diet, has a positive impact on health, but little is known about the effects of including unhealthy foods in an otherwise healthy diet. Now researchers at Rush University Medical Center have reported diminished benefits of a Mediterranean diet among those with high frequency of eating unhealthy foods. The results of their study were published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association on Jan. 7.
"Eating a diet that emphasizes vegetables, fruit, fish and whole grains may positively affects a person's health," said Puja Agarwal, PhD, a nutritional epidemiologist and assistant professor in the Department of Internal Medicine at Rush Medical College. "But when it is combined with fried food, ...
In a technique known as DNA origami, researchers fold long strands of DNA over and over again to construct a variety of tiny 3D structures, including miniature biosensors and drug-delivery containers. Pioneered at the California Institute of Technology in 2006, DNA origami has attracted hundreds of new researchers over the past decade, eager to build receptacles and sensors that could detect and treat disease in the human body, assess the environmental impact of pollutants, and assist in a host of other biological applications.
Although the principles of DNA origami are straightforward, the technique's tools and methods for designing new structures are not always easy to grasp and have not been well documented. In addition, scientists new to the method have had no single reference they ...
Canada is at the forefront of global efforts to end child marriage abroad. Yet this practice remains legal and persists across the country. In Canada, more than 3,600 marriage certificates were issued to children, usually girls, under the age of 18 between 2000 and 2018, according to a new study from researchers at McGill University. In recent years, an increasing number of child marriages have been common-law unions.
Child marriage, defined as formal or informal (common-law) marriage before the age of 18, is a globally-recognized indicator of gender inequality because the negative consequences for ...
BOSTON - Patients with tuberous sclerosis complex, a genetic disorder characterized by the growth of noncancerous tumors in multiple organs of the body, have limited treatment options. A team led by investigators at Massachusetts General Hospital (MGH) has now shown that gene therapy can effectively treat mice that express one of the mutated genes that cause the disease. The research is published in Science Advances.
The gene, called TSC2, codes for tuberin, a protein that acts to inhibit cell growth and proliferation. When mutations occur in TSC2, resulting in a lack of tuberin in cells, the cells enlarge ...
ORLANDO, Jan. 8, 2021 - Florida's threatened coral reefs have a more than $4 billion annual economic impact on the state's economy, and University of Central Florida researchers are zeroing in on one factor that could be limiting their survival - coral skeleton strength.
In a new study published in the journal Coral Reefs, UCF engineering researchers tested how well staghorn coral skeletons withstand the forces of nature and humans, such as impacts from hurricanes and divers.
The researchers subjected coral skeletons to higher stresses than those caused by ocean waves, says Mahmoud Omer, a doctoral student in UCF's Department ...
A research team at the University of Basel has discovered immune cells resident in the lungs that persist long after a bout of flu. Experiments with mice have shown that these helper cells improve the immune response to reinfection by a different strain of the flu virus. The discovery could yield approaches to developing longer-lasting vaccinations against quickly-mutating viruses.
At the start of the coronavirus pandemic, some already began to raise the question of how long immunity lasts after weathering SARS-CoV-2. The same question has now arisen regarding the COVID-19 vaccination. A key role is played by immunological memory - a complex interplay of immune cells, antibodies and signaling ...
